Compare Ginkgo Bioworks Holdings Inc (DNA) vs Invesco Solar ETF (TAN) Price & Performance

Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.

DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.

TAN (Invesco Solar ETF) trades at $43.75, up 0.51% with bearish technical signals from moving averages. The solar sector faces headwinds from high borrowing costs impacting project financing, as recent news highlights sector volatility. Technical indicators show 16 sell signals versus 1 buy, with key resistance at $44 and support at $43. The ETF's expense ratio of 0.7% is higher than broader energy alternatives, contributing to its underperformance versus the S&P 500 over five years.

Outlook remains cautious due to sector-specific risks including interest rate sensitivity and market saturation concerns. Investment opportunity exists for long-term renewable energy exposure, but risks include policy uncertainty, cost pressures, and competitive ETF alternatives with lower fees. The bearish technical setup suggests near-term pressure despite potential long-term energy transition tailwinds.